Lataa...
Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment among Older Adults in the United States, 2000–2015
BACKGROUND: Despite several new medications being FDA-approved for overactive bladder (OAB) and new prescription drug payment programs, there are limited population-based data regarding OAB medication use among older adults. OBJECTIVES: To examine (1) impacts of new medications and $4 generic progra...
Tallennettuna:
| Julkaisussa: | Med Care |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5766403/ https://ncbi.nlm.nih.gov/pubmed/29287033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MLR.0000000000000858 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|